Business
Medtronic Diabetes announces FDA clearance for MiniMed Go™ Smart MDI system featuring Instinct sensor made by Abbott
Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its MiniMed Go™ app. The MiniMed Go™ Smart Multiple Daily Injection (MDI) system seamlessly integrates the InPen™ smart insulin pen with the Instinct sensor made by Abbott — all connected through the MiniMed Go™ app. This powerful combination delivers real-time, personalized insights and actionable guidance, including:
About this update from Medtronic Plc.
[{"type":"text","content":"MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily injections","length":204,"tagName":"p","attribs":{}},{"type":"text","content":"GALWAY, Ireland, Jan. 12, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its MiniMed Go™ app. The MiniMed Go™ Smart Multiple Daily Injection (MDI) system seamlessly integrates the InPen™ smart insulin pen with the Instinct sensor made by Abbott — all connected through the MiniMed Go™ app. This powerful combination delivers real-time, personalized insights and actionable guidance, including:","length":513,"tagName":"p"},{"type":"image","alt":"Ambar, 17, MiniMed Champion and InPen™ user since 2022+","displaySize":"","headline":null,"caption":"Ambar, 17, MiniMed Champion and InPen™ user since 2022+","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":300,"url":"https://media.zenfs.com/en/prnewswire.com/7f97c82c1f4508ea5e9ad958a9f63748"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/awMBRYGtDLFalbRnIi0wtA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTUyOTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/7f97c82c1f4508ea5e9ad958a9f63748","width":400,"height":300}},"href":"https://mma.prnewswire.com/media/2859332/Ambar.html","hrefExternal":true,"rel":"nofollow"},{"type":"list","items":[{"val":[{"type":"text","content":"Missed dose alerts to help minimize glucose highs","length":49,"tagName":"p"}]},{"val":[{"type":"text","content":"A dose calculator that simplifies dose decision-making","length":54,"tagName":"p"}]},{"val":[{"type":"text","content":"Action-oriented guidance if a user misses or miscalculates a dose","length":65,"tagName":"p"}]},{"val":[{"type":"text","content":"CareLink™ software reporting for easier provider collaboration","length":62,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":230,"olType":false},{"type":"text","content":"The MiniMed Go™ system is cleared for individuals with insulin-requiring type 1 and type 2 diabetes aged 7 years and older, as well as for children ages 2 to 6 years under the supervision of an adult caregiver. Compatibility of the Simplera™ sensor with MiniM...